SLC38A7 and neoplasm: To sum up, targeting the amino acid transporters and metabolic enzymes related to amino acid metabolism reprogramming in TME is a hopeful strategy for tumor treatment, which can enhance anti-tumor immunity and inhibit the proliferation and metastasis of tumors with immune checkpoint inhibitors (17).